Hot Movers: Novartis AG (NYSE:NVS), IMAX Corporation (NYSE:IMAX), ImmunoGen (NASDAQ:IMGN), bluebird bio (NASDAQ:BLUE), Randgold Resources (NASDAQ:GOLD)

Novartis AG (ADR) (NYSE:NVS) announced today the submission of a Biologic License Application (BLA) to the US Food and Drug Administration (FDA) for marketing approval for the use of Bexsero® (Multicomponent Meningococcal Group B Vaccine [recombinant, adsorbed]) to help protect against invasive meningococcal disease caused by serogroup B (meningitis B) in adolescents and young adults from 10 years through 25 years of age. Novartis AG … Continue reading Hot Movers: Novartis AG (NYSE:NVS), IMAX Corporation (NYSE:IMAX), ImmunoGen (NASDAQ:IMGN), bluebird bio (NASDAQ:BLUE), Randgold Resources (NASDAQ:GOLD)

Losers At Healthcare: Synageva BioPharma (NASDAQ:GEVA), Auspex Pharmaceuticals (NASDAQ:ASPX), ImmunoGen (NASDAQ:IMGN), Infinity Pharmaceuticals Inc. (NASDAQ:INFI)

Synageva BioPharma Corp (NASDAQ:GEVA) last released its earnings data on Friday, May 2nd. The company reported ($1.16) earnings per share for the quarter, beating the analysts’ consensus estimate of ($1.19) by $0.03. Analysts expect that Synageva BioPharma Corp will post $-5.90 EPS for the current fiscal year. Synageva BioPharma Corp (NASDAQ:GEVA)stock performance was 5.87% in last session and finished the day at $ 85.40. Traded … Continue reading Losers At Healthcare: Synageva BioPharma (NASDAQ:GEVA), Auspex Pharmaceuticals (NASDAQ:ASPX), ImmunoGen (NASDAQ:IMGN), Infinity Pharmaceuticals Inc. (NASDAQ:INFI)

Zalicus Inc (NASDAQ:ZLCS) will merge with Epirus Biopharmaceuticals in an all-stock transaction. Zalicus will be known as Epirus and will operate under the latter company’s management team led by Amit Munshi as president and CEO. Current Zalicus Inc (NASDAQ:ZLCS) stockholders will own approximately 19% of the company. The merger will create a publicly-traded company listed on the NASDAQ. Zalicus Inc (NASDAQ:ZLCS) stock performance was 31.07% … Continue reading Biotech Unusual Volume: Zalicus Inc (NASDAQ:ZLCS), ImmunoGen (NASDAQ:IMGN), Transition Therapeutics (NASDAQ:TTHI), Lpath (NASDAQ:LPTN)

Shares of ImmunoGen Inc. (NASDAQ:IMGN), a biopharmaceutical company focused on developing therapies to fight cancer, advanced as much as 15% after research firm Canaccord Genuity initiated coverage on the company. ImmunoGen, Inc. (NASDAQ:IMGN) stock performance was 11.02% in last session and finished the day at $14.21. Traded volume was 2.85million shares in the last session and the average volume of the stock remained 858.46K shares. … Continue reading Biotech bullish Stocks: ImmunoGen (NASDAQ:IMGN), OXiGENE Inc (NASDAQ:OXGN), BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), Celldex Therapeutics (NASDAQ:CLDX)

On Oct. 28, Ventana Medical Systems, Inc. announced it has entered into an agreement with ImmunoGen, Inc. (NASDAQ:IMGN) to collaborate on the development of biomarker assays and a companion diagnostic immunohistochemistry (IHC) test for one or more of ImmunoGen’s product candidates. ImmunoGen, Inc. (NASDAQ:IMGN) belongs to Healthcare sector. Its weekly performance is 5.83%. On last trading day company shares ended up $9.26. ImmunoGen, Inc. (NASDAQ:IMGN) … Continue reading Stock Highlights: ImmunoGen, Inc. (NASDAQ:IMGN), Huntington Bancshares Incorporated (NASDAQ:HBAN), Ohio Valley Banc Corp. (NASDAQ:OVBC), SMTP, Inc. (NASDAQ:SMTP), Gol Linhas Aereas Inteligentes (NYSE:GOL)

On Oct 10, ImmunoGen, Inc. (NASDAQ:IMGN) announced that the Company will host a conference call at 8:00 a.m. ET on Friday October 24 2014 to discuss ImmunoGen’s financial results for the three-month period ended September 30 2014 the first quarter of its 2015 fiscal year. ImmunoGen, Inc. (NASDAQ:IMGN) belongs to Healthcare sector. Its weekly performance is 2.74%. On last trading day company shares ended up … Continue reading Market Movers : ImmunoGen, Inc. (NASDAQ:IMGN), Ford Motor Company (NYSE:F), AT&T, Inc. (NYSE:T), Stanley Black & Decker, Inc. (NYSE:SWK), Computer Programs & Systems Inc. (NASDAQ:CPSI)